SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.749-5.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eric Jacobson who wrote (3056)11/19/1996 12:49:00 PM
From: vegetarian   of 14328
 
Eric thanks for posting the information.
It appears that the competition is heating up and Triby needs to move fast.
Is there any data available on how Triby is doing with Unigold HIV test in countries other than USA? that is, if they have started marketing, how much they are shipping/have shipped?
The importance of timely filing for FDA approval becomes even more important if triby is to gain ground in US market.
Also, if they have not already started marketing HIV Unigold tests Internationally, a late entry may pose a significant obstacle if other's brands get established even if Unigold technology may be slightly better (since Beacon is Saliva based etc).
Having more competition is not necessarily bad because it implies more players are seeing a large market share but getting products out of the door quick is more important in this game.
Can anyone familiar with the rapid HIV technology comment on how difficult it is technically for another US company to come out with one step Saliva based technology (equivalent to Unigold)? that could have potential of a serious threat to Triby.

M. Carter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext